The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kovaleva Yu.S.

Altai Medical State University, Barnaul, Russia

Vedler A.A.

GBOU VPO «Altajskij gosudarstvennyj meditsinskij universitet» Minzdrava Rossii, Barnaul, Rossija, 656038

Kozhevnikova P.E.

Altay State Medical University, Barnaul, Russia

The role of ceramides in preserving the epidermal barrier

Authors:

Kovaleva Yu.S., Vedler A.A., Kozhevnikova P.E.

More about the authors

Read: 5954 times


To cite this article:

Kovaleva YuS, Vedler AA, Kozhevnikova PE. The role of ceramides in preserving the epidermal barrier. Russian Journal of Clinical Dermatology and Venereology. 2019;18(4):513‑518. (In Russ.)
https://doi.org/10.17116/klinderma201918041513

Recommended articles:
Infe­ctious factors in atopic dermatitis, pharmaceutical possibilities (systematic lite­rature review). Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):7-15
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Search of diagnostic and prognostic biomarkers of immu­noinflammatory dermatoses by means of flow cyto­metry. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):170-177
Nucleotide sequence variants in IL4 and TNFA genes in patients with dermatoses and xero­sis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):178-184
Historical aspe­cts and prospects of psoriasis treatment. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):284-292
Asse­ssment of the serum inte­rleukin 33 (IL-33) level in patients with atopic dermatitis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):293-296
Key specific tools for asse­ssment of life quality of patients with psoriasis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):319-325
Psychodermatological aspe­cts of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):403-411

References:

  1. Suvorova KN, Togoeva LT, Grishko TN. et al. Corneotherapy in inflammatory and desquamative dermatosis in children. Questions of modern pediatrics. 2005;4(6):39-44. (In Russ.)
  2. Murashkin NN. Disturbances of the dermal barrier as a factor in the chronization of dermatoses in childhood, approaches to therapy: theoretical and practical innovations. Attending doctor. 2014;6:19-23. (In Russ.)
  3. Kligman AM. Corneobiology and Corneotherapy — a final chapter. International Journal of Cosmetic Science. Vol. 33, Issue 3, June 2011.
  4. Norlen L. New views on the formation, structure and functioning of the skin barrier and their practical significance. Cosm med. 2002;5:8-17. (In Russ.)
  5. Skripkin YuK. Skin and venereal diseases. A guide for physicians in 4 tons. T. 3. M.: 1995:239-292. (In Russ.)
  6. Matushevskaya EV, Svirschevskaya EV. Medicinal Micronization Technologies: New Opportunities for Topical Glucocorticosteroids in Dermatology. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2017;16(1):43-48. (In Russ.) https://doi.org/10.17116/klinderma201716143-48
  7. Pashinyan AG, Heydar SA, Harutyunyan GB. Moisturizing the skin as a factor in the prevention of premature aging. Bulletin of Dermatology and Venereology. 2013;4:104-107. (In Russ.)
  8. Khlebnikova AN, Petrunin DD, Molochkov AV. Lipids of the human epidermis (fundamental information and clinical implementation). Study Guide. M.: 2015:26-28. (In Russ.)
  9. Motta S, Monti M, Sesana S, et al. Ceramide composition of the psoriatic scale. Biochim. Biophys. Acta. 1993;1182(2):147-151.
  10. Murashkin NN. Disturbances of the dermal barrier as a factor in the chronization of dermatoses in childhood, approaches to therapy: theoretical and practical innovations. Attending doctor. 2014;6:19-23. (In Russ.)
  11. Bolotnaya LA. New approaches to external therapy for chronic eczema. Ukrainian Journal of Dermatology, Venereology, Cosmetology. 2012;2(45):68-75. (In Russ.)
  12. Belousova TA, Goryachkina MV. Modern ideas about the structure and function of the skin barrier and the therapeutic possibilities of correcting its disorders. Rus Med J. 2004;12(18):1082-1084. (In Russ.)
  13. Namazova LS, Voznesenskaya NI, Surkov AG. Atopic dermatitis. Attending Physician. 2006;4:72-78. (In Russ.)
  14. Leung D, Nicklas R, Li J, Bernstein I. et al. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Ann. Allergy Asthma Immunol. 2004;9(Suppl.2):1-21.
  15. Ishikawa J, Abe A, Jin K. et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol. 1991;96(4):523-526.
  16. Janssens M, van Smeden J, Gooris GS. et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J. Lipid Res. 2012;53(12):2755-2766.
  17. Belousova TA. New in the treatment of dandruff and seborrheic dermatitis. J mos dermatol. 2018;1(21). (In Russ.)
  18. Rosentul MA. General therapy for skin diseases. M.: 1952. (In Russ.)
  19. Simpson EL, Berry TM, Brown PA, Hanifin JM. A Pilot Study of Emollient Therapy for the Primary Prevention of Atopic Dermatitis. J. Am. Acad. Dermatol. 2010;63(4):587-593.
  20. Mao-Qiang M, Brown BE, Wu-Pong S. et al. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch. Dermatol. 1995;131(7):809-816.
  21. Man MQ, Feingold KR, Thornfeldt CR, Elias PM. Optimization of physiological lipid mixtures for barrier repair. J. Invest. Dermatol. 1996;106(5):1096-1101.
  22. Man MQ, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch. Dermatol. 1993;129(6):728-738.
  23. Chamlin SL, Frieden IJ, Fowler A, et al. Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. Arch. Dermatol. 2001;137(8):1110-1112.
  24. Kircik LH, Del Rosso JQ, Aversa D. Evaluating clinical use of a ceramidedominant, physiologic lipid-based topical emulsion for atopic dermatitis. J. Clin. Aesthetic Dermatol. 2011;4(3):34-40.
  25. Bikowski J. Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitis. J. Drugs. Dermatol. 2009;8(11):1037-1041.
  26. Chamlin SL, Kao J, Frieden IJ. et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J. Am. Acad. Dermatol. 2002;47(2):198-208.
  27. Uchida Y, Holleran WM, Elias PM. On the effects of topical synthetic pseudoceramides: comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramides. J. Dermatol. Sci. 2008;51(1):37-43.
  28. Lee YB, Park HJ, Kwon MJ. et al. Beneficial effects of pseudoceramide-containing physiologic lipid mixture as a vehicle for topical steroids. Eur. J. Dermatol. 2011;21(5):710-716.
  29. Awad AB, Toczek J, Fink CS. Phytosterols decrease prostaglandin release in cultured P 388 D1/MAB macrophages. Prostaglandins Leukot Essent Fatty Acids. 2004;70(6):511-520.
  30. Protsenko TV, Protsenko OA. Dry skin syndrome in dermatology: mechanisms of formation and medical and cosmetic care. Ukr J Dermatol Venereol Cosmetol. 2009;3:62-65. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.